HomeREGULATORY
REGULATORY

CSIMC Recommends NHI Price Listing for 15 APIs/20 Products
(Sep.7.2011)

At a general meeting on September 7, the Central Social Insurance Medical Council (CSIMC; Chuikyo) recommended NHI price listing for 15 APIs (active pharmaceutical ingredients)/20 products, including AstraZeneca’s proton pump inhibitor (PPI) Nexium capsule 10 mg and 20 mg (esomeprazole magnesium) and Astellas Pharma’s treatment for overactive bladder Betanis Tablet 25 mg and 50 mg (mirabegron). The adrenal hormone preparation EpiPen Injection 0.15 mg and 0.3 mg (adrenaline) will be added to the NHI price list on September 22. Other products will be included in the NHI price list on September 12.
> Read full story

Commentary

Ex-Health Minister Tamura’s Clout Likely to Grow in Nagatacho

Lexicon

Drug requiring guidance:
要指導医薬品

The Column

Successful People Have the Best Information

Archives

Health Ministry Eyes Future Genomic Data Registration at National Medical Centers(Oct.21)
JPMA Tones Down Demand on R&D Tax Credit System, Calls for “Maintenance” Instead of “Perpetuation”(Oct.20)
Alexion Submits NDA for Hypophosphatasia Treatment Asfotase Alfa(Oct.20)
Seikagaku Establishes Representative Office in US(Oct.20)
Astellas to End License Agreement with US Venture Company for AD Treatments(Oct.20)

Most Read

1.
4 Die after Tak...
2.
MOF Panel to Pi...
3.
JMA Pres. Frets...
4.
Pfizer Japan Vo...
5.
National Health...

News Calendar